A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial

Hum Gene Ther. 2000 Jun 10;11(9):1355-68. doi: 10.1089/10430340050032447.
No abstract available

MeSH terms

  • Clinical Protocols*
  • Clinical Trials, Phase I as Topic / methods*
  • Drug Combinations
  • Gene Expression
  • Genetic Therapy*
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / genetics
  • Interleukin-2 / therapeutic use*
  • Melanoma / immunology
  • Melanoma / pathology
  • Melanoma / therapy*
  • Neoplasm Metastasis
  • Plasmids
  • Superantigens / administration & dosage
  • Superantigens / genetics
  • Superantigens / therapeutic use
  • Vaccines, DNA / therapeutic use*

Substances

  • Drug Combinations
  • Interleukin-2
  • Superantigens
  • Vaccines, DNA